Investment management team update

RNS Number : 3688T

BB Healthcare Trust PLC

20 March 2019

 

20 March 2019

BB Healthcare Trust plc

Investment management team update

The Board of BB Healthcare Trust plc (the "Trust" or "BB Healthcare") today announces an update to the Trust's investment management team at Bellevue Asset Management AG ("Bellevue"). Bellevue has informed the Board that Dr Daniel Koller will step back from his role within the Trust's investment management team to focus on BB Biotech AG ("BB Biotech").

BB Healthcare will continue to be advised by its Investment Advisory Team of Paul Major and Brett Darke based in London. It was always expected that Dr Koller would step back as the Trust evolved, and Bellevue has confirmed that it will continue to provide in depth support to the Trust and fulfil its obligations under the delegated portfolio management agreement. BB Biotech and BB Healthcare Trust will continue to co-operate closely with their in-depth bottom-up stock selection and analytical processes.

Justin Stebbing, Chairman, commented: "The Board would like to thank Daniel for his support of Paul and Brett during the early years of this project, and we wish him continued success in the future. BB Healthcare's Investment Team has delivered strong results for investors in these early years and the Board has every confidence that they will continue to deliver moving forward."

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014.

The Company's LEI is: 213800HQ3J3H9YF2UI82

For further information please contact:

Bellevue Advisors Limited
Paul Major	[phone]
Brett Darke	[phone]
Claude Mikkelsen	[phone]
Peel Hunt LLP	[phone]
Liz Yong, Helen Rennardson (Corporate Broking)
Mark Thompson, Chris Bunstead (Sales)
J.P. Morgan Cazenove	[phone]
William Simmonds
Ed Murray
Eddie Nissen (Sales)
Oliver Kenyon
Maitland/amo - Financial PR	[phone]
William Clutterbuck

 

END

 

 

MSCCKCDPKBKBPND